24小时热门版块排行榜

>论坛更新日志 (3113)
>虫友互识 (202)
>文献求助 (198)
>导师招生 (173)
>考博 (109)
>休闲灌水 (72)
>招聘信息布告栏 (55)
>硕博家园 (52)
>论文投稿 (45)
>博后之家 (43)
>基金申请 (43)
>考研 (38)
>论文道贺祈福 (36)
>公派出国 (36)
>找工作 (35)
>教师之家 (27)

返回列表

当前主题已经存档。

【悬赏金币】回答本帖问题，作者gufansmile将赠送您 6 个金币

gufansmile

铜虫 (小有名气)

应助: 0 (幼儿园)
金币: 74
帖子: 180
在线: 1.1小时
虫号: 245250
注册: 2006-04-23
专业: 微生物与生化药学

[求助] l论文投稿求助！【有效期至2008年12月1日】求助完成

请问各位有没有投过journal of enzyme inhibition and medicinal chemistry这个杂志，这个杂志的投稿方式是邮寄到主编邮箱吗？一般审稿日期是多久呢？这个被接收的过程大概需要多久啊?

谢谢大家的回答，毕业在即，万分着急，请给予指导，谢谢各位了啊!

[ Last edited by gufansmile on 2008-10-22 at 12:15 ]

回复此楼

» 猜你喜欢

1楼 2008-10-18 10:46:08

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

crazyff12345

金虫 (正式写手)

博学EPI: 21
应助: 2 (幼儿园)
金币: 216.7
散金: 36
红花: 7
帖子: 964
在线: 156小时
虫号: 248188
注册: 2006-05-03
性别: GG
专业: 质谱分析

★
sanko211(金币+1,VIP+0):代楼主发金币，感谢应助，欢迎常来有奖问答版^_^

3. Submission of Manuscripts

Authors are encouraged to submit manuscripts electronically by email to Professor H. John Smith at jeimc@Cardiff.ac.uk. Electronic submissions should be sent as email attachments using a standard word processing program, such as MSWORD.

If email submission is not possible, please send to the above address an electronic version on disk along with three paper copies together with one set of high quality figures for reproduction. When the accepted paper is submitted in final form, please send two paper copies and a copy on disk.

Please make sure your contact address information is clearly visible on the outside of all packages you are sending to the Editor.

4. Preparation of Manuscripts

Journal of Enzyme Inhibition and Medicinal Chemistry considers all manuscripts on the strict condition that they have been submitted only to Journal of Enzyme Inhibition and Medicinal Chemistry, that they have not been published already, nor are they under consideration for publication or in press elsewhere. Authors who fail to adhere to this condition will be charged with all costs which Journal of Enzyme Inhibition and Medicinal Chemistry incurs and their papers will not be published.

Research article contributions to Journal of Enzyme Inhibition and Medicinal Chemistry must report original research and all manuscripts will be subjected to review by referees. The following guidelines apply:

For all manuscripts non-discriminatory language is mandatory. Sexist or racist terms should not be used.
Each paper should have three to six keywords.
Papers are accepted only in English.
Manuscripts for hard-copy submission should be typed on single sides of good quality white A4 or 8 x 11 inch paper, double-spaced throughout including the reference section, with wide (3 cm) margins.
All the authors of a paper should include their full names, affiliations, postal addresses, telephone and fax numbers and email addresses on the cover page of manuscripts.
Abstracts of 100 - 150 words are required for all papers submitted and should precede the text of a paper.
Manuscripts should be compiled in the following order: title page; abstract; keywords; main text; acknowledgments; appendixes (as appropriate); references; table(s) with caption(s) (on individual sheets); figure caption(s) (as a list).
Section headings should be concise and numbered sequentially, using a decimal system for subsections.
Authors must adhere to SI units.
For information on submitting animations, movie files and sound files or any additional information including indexes and calendars please click here.
When using a word which is or is asserted to be a proprietary term or trade mark authors must use the symbol ® or ™ or alternatively a footnote can be inserted using the wording below:

This article includes a word that is or is asserted to be a proprietary term or trade mark. Its inclusion does not imply it has acquired for legal purposes a non-proprietary or general significance, nor is any other judgement implied concerning its legal status.
5. Ethics and Consent

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients' names, initials, or hospital numbers, especially in illustrative material. Papers including animal experiments or clinical trials must be conducted with approval by the local animal care or human subject committees, respectively.

Identifying information should not be published in written descriptions, photographs, and pedigrees, unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published.

6. Declaration of Interest

It is the policy of all Informa Healthcare, to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE). (http://www.icmje.org/index.html#conflict)

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organisation with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.

All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading "Declaration of interest" and where available within the appropriate field on the journal's Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.

If no conflict is declared, the following statement will be attached to all articles:

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgements on conclusions drawn.

7. Authorship Contributions

Contributions must be substantial in order to warrant authorship. Each author should have participated sufficiently in the work to take public responsibility for the content. All other contributors should be listed as acknowledgements.

8. Colour Charges

Any figure submitted as a colour original will appear in colour in the journal's online edition free of charge and can be downloaded. Paper copy colour reproduction will only be considered on condition that authors contribute to the associated costs. The charges are 500/US$900 for the first colour page and 250/US$450 for each colour page after per article.

There are no charges for non-colour pages.

9. Proofs

The Editor reserves the right to proceed to press without submitting page proofs to the author. However, usual practice will involve corresponding authors receiving e-mail notification with a password and Web address from which to download a PDF. Hard copies of proofs will not be mailed. To avoid delays in publication, corrections to proofs must be returned within 48 hours, by electronic transmittal, fax or mail. Authors will be charged for excessive correction at this stage of production.

If authors do not return page proofs promptly, the Editor reserves the choice to either delay publication to a subsequent issue or to proceed to press without author corrections.

10. Offprints and Reprints

Offprints and reprints of articles published in Journal of Enzyme Inhibition and Medicinal Chemistry can be purchased once the article has been published online. You will be given the opportunity to order offprints and/or reprints via Rightslink® at the time at which you receive proofs of your article. Copies of the Journal can be purchased at the authors' preferential rate of 15.00/$25.00 per copy.

11. Copyright

It is a condition of publication that authors assign copyright or license the publication rights in their articles, including abstracts, to Informa UK Ltd. This enables us to ensure full copyright protection and to disseminate the article, and the Journal, to the widest possible readership in print and electronic formats as appropriate. Authors may, of course, use the article elsewhere after publication without prior permission from Informa UK Ltd., provided that acknowledgement is given to the Journal as the original source of publication, and that Informa Healthcare is notified so that our records show that its use is properly authorised. Authors retain a number of other rights under the Informa UK Ltd. rights policies documents. These policies are referred to at the Copyright FAQs page.

Authors are themselves responsible for obtaining permission to reproduce copyright material from other sources. See Copyright Permission for full details.

A copyright agreement form can be downloaded by corresponding authors of accepted manuscripts with proofs. This should be signed and returned to Taylor & Francis